Bonti Announces Close of $15.5 Million Series C Funding and Appointment of David Ramsay as Chief Financial Officer
23.01.2018
Latest Financing to Enable Continued Clinical Development of Lead Product EB-001 to Treat Musculoskeletal Pain
News
Immusoft raises $3M, appoints new CEO as it approaches clinical trials
05.01.2018
The funding is first part of the company’s ongoing Series B round.
Bonti to Present at Two Prestigious Healthcare Conferences
05.01.2018
Fauad Hasan, CEO and Co-founder, to Spotlight the Company in San Francisco.
IAG is to present at annual meeting of the Radiological Society of North America (RSNA)
24.11.2017
The company will present their latest scientific work in advanced quantitative image analysis in renal cell carcinoma (RCC) in collaboration with the Peter MacCallum Cancer Center, Melbourne, Australia.
IAG Partners with Leading Academics to Provide AI-powered MRI Analysis of Scleroderma
23.10.2017
IAG, the Image Analysis Group has partnered with the academics from the Faculty of Medicine and Health of the University of Leeds, UK to commercialise proprietary IP and research into imaging biomarkers for scleroderma; the venture has already received initial funding.